In this article, Sino Biological demonstrates how Chimeric Antigen Receptors (CARs) can be utilized in novel cancer therapies, a change from the usual application of CARs, which heavily feature T-cells.
Innovent and Laekna Jointly Announce First Patient Dosed with Three-drug Combination in a Phase 1/2 Study for the Treatment of Patients with Solid Tumors Who Were Resistant to Prior Anti-PD-1/PD-L1 Therapy - read this article along with other careers information, tips and advice on BioSpace
In this article, Sino Biological discusses how stem cells can be used to support and aid cancer therapy and treatment. They discuss different types of stem cells, pathways to target and how to best produce them.